Zoetis | ZTS - Interest Expense On Debt


Zoetis reported $61M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Align Technology USD 9.96M 3.02M Jun/2026
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 403M 4M Sep/2026
Charles River Laboratories USD 30.34M 3.6M Jun/2026
Coherus Biosciences USD 2.25M 76K Dec/2025
Dentsply International USD 22M 2M Jun/2026
Eli Lilly USD 316M 201.3M Sep/2026
Henry Schein USD 43M 4M Jun/2026
Idexx Laboratories USD 10.18M 2.44M Jun/2026
Illumina USD 24M 0 Jun/2026
IQVIA Holdings USD 203M 6M Sep/2026
J&J USD 43M 25M Mar/2026
Laboratory Of America USD 59.1M 2M Sep/2026
Merck USD 525M 46M Jun/2026
Neogen USD 13.8M 100K Jun/2026
Pacira USD 3.62M 77K Jun/2026
Perrigo USD 7.61B 373.8M Jun/2026
Pfizer USD 667M 4M Jun/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Quest Diagnostics USD 61M 8M Sep/2026
Sanofi EUR 287M 109M Jun/2026
Sanofi EUR -25M 99.78M Dec/2025
Zoetis USD 61M 1000K Jun/2026